Approval of malaria drugs as Covid-19 treatment revoked in the US
The Unites States Food and Drug Administration (F.D.A.) has announced that they will revoke the emergency authorization for the usage of two malaria drugs as treatment for Covid-19. In the statement the F.D.A. states that the drugs are "unlikely to produce an antiviral effect".